Obstetrics & Gynecology · Houston, TX
NPI
1073515201
Since 2005
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2201 W Holcombe Blvd Ste 330
Houston, TX, 77030
Phone (713) 799-1635
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
287 services
Medicare patients, 2024
196
Average age 74
Drug cost, 2024
$117K
859 prescriptions
Company payments, 2025
$62.17
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark A Jacobs was code 99214 (office e&m - established), 129 times for 107 patients. In total Mark A Jacobs billed 287 services in 14 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 129 | 107 | $89.42 | $12K |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 95 | 95 | $39.53 | $3,755 |
| 99213 Office E&M - Established | Office | 25 | 15 | $61.88 | $1,547 |
| 87210 General Laboratory | Office | 16 | 14 | $5.70 | $91.2 |
By year: 2022 $14K for 211 services; 2023 $18K for 262 services; 2024 $19K for 287 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87210 General Laboratory | 16 | 14 | $5.70 | $91.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark A Jacobs prescribed most often to Medicare patients was Estradiol, with 224 prescriptions and refills. In total Mark A Jacobs wrote 859 Medicare prescriptions that cost $117K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 224 | 646 | 99 | $13K |
| Premarin Estrogens, Conjugated | 80 | 178 | 22 | $30K |
| Raloxifene Hcl Generic | 66 | 170 | 17 | $2,420 |
| Prempro Estrogen,con/M-Progest Acet | 39 | 91 | Under 11 | $22K |
| Valacyclovir Valacyclovir Hcl | 37 | 82 | 11 | $1,362 |
| Alendronate Sodium Generic | 37 | 104 | 15 | $366 |
| Estradiol (Twice Weekly) Estradiol | 28 | 71 | Under 11 | $3,126 |
| Fluconazole Generic | 24 | 24 | 17 | $230 |
| Progesterone Progesterone, Micronized | 23 | 63 | Under 11 | $687 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 21 | 37 | Under 11 | $1,078 |
| Medroxyprogesterone Acetate Generic | 21 | 55 | Under 11 | $121 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 20 | 20 | 18 | $319 |
| Clobetasol Propionate Generic | 17 | 17 | Under 11 | $337 |
| Yuvafem Estradiol | 14 | 38 | Under 11 | $2,724 |
| Duavee Estrogens,conj/Bazedoxifene | 13 | 37 | Under 11 | $6,694 |
Brand drugs: 212 claims; generic drugs: 647 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark A Jacobs $62.17 ($62.17 in general payments such as food, travel and fees) from 6 companies. The largest payer was Exact Sciences Corporation with $40.3.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.